# Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old

> **NCT00967759** · PHASE3 · WITHDRAWN · sponsor: **Ache Laboratorios Farmaceuticos S.A.**

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** Bronpheniramine and fenilefrine (Decongex Plus)
- **DRUG:** Bronpheniramine isolated
- **DRUG:** Fenilefrine isolated

## Key facts

- **NCT ID:** NCT00967759
- **Lead sponsor:** Ache Laboratorios Farmaceuticos S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was designed again in compliance with the regulatory agency.
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967759, "Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00967759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*